Heartsciences Inc (HSCS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Heartsciences Inc-Aktie (HSCS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	27.32% 0.00242	0.0019	0.00435	-	-
Cost Of Revenue	32.63% 0.00101	0.00076	-	-	-
Gross Profit	23.77% 0.00141	0.00114	-	-	-
Operating Expenses	10.64% 2.0748	1.8753	1.9229	2.3715	1.985
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	10.65% 2.0758	1.876	-	-	-
Operating Income/Loss	10.63% -2.0734	-1.8741	-1.9204	-2.3715	-1.985
Nonoperating Income/Loss	53.35% -0.2774	-0.1809	-0.1739	-0.1648	-0.0979
Income/Loss From Continuing Operations Before Tax	27.32% 0.00242	0.0019	6.6752	-2.5363	-2.0829
Income/Loss From Continuing Operations After Tax	14.39% -2.3508	-2.055	-2.0943	-2.5363	-2.0829
Net Income/Loss	14.39% -2.3508	-2.055	-2.0943	-2.5363	-2.0829
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	113.30% 2.7805	1.3035	0.0442	0.9861	0.9174
Diluted Average Shares	113.30% 2.7805	1.3035	0.0442	0.9861	0.9174
Basic Earnings Per Share	46.20% -0.85	-1.58	-1.88	-2.57	-2.27
Diluted Earnings Per Share	46.20% -0.85	-1.58	-1.88	-2.57	-2.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$91.00

0.12%

STE

$219.97

0.58%

DXCM

$63.21

1.59%

PHG

$27.20

0.33%

GEHC

$70.40

0.07%

$81.19

0.17%